FIELD: chemistry.
SUBSTANCE: invention relates to the field of bioorganic and medical chemistry and pharmacology and can be used for development of new antiaggregatory drugs. Disclosed is use of compounds of general formula (values of substitutes are specified in cl. 1 of the invention) as antiaggregatory agents. Invention also relates to isoxazole derivatives: 5-(3-methylbutyl)-3-(3-pyridyl)-4,5-dihydroisoxazole, 5-(2-naphthyl)-3-(3-pyridyl)-4,5-dihydroisoxazole, 5-(7-(N,N-diethylamino)-2-oxo-2H-1-benzopyran-3-yl)-3-(3-pyridyl)-4,5-dihydroisoxazole, 3-(3-pyridyl)-5-cyclohexylisoxazole and 5-(2-naphthyl)-3-(3-pyridyl) isoxazole.
EFFECT: technical result is the use of isoxazole derivatives as antiaggregatory agents.
2 cl, 2 tbl, 8 ex, 3 dwg
Title | Year | Author | Number |
---|---|---|---|
5-ALKYL-3-(PYRID-3-YL)ISOXAZOLES AND 4,5-DIHYDRO-DERIVATIVES THEREOF, HAVING ANTI-AGGREGATION ACTIVITY | 2013 |
|
RU2565754C2 |
5-(4'-HYDROXYPHENYL)-AND 5-(2',5'-DIHYDROXYPHENYL)-6 H-1,3,4-THIADIAZINE-2-AMINES, HYDROHALOGENIDES INHIBITING THROMBOCYTE AGGREGATION IN INTRAVENOUS INTRODUCTION | 2009 |
|
RU2458060C2 |
SUBSTITUTED ω-AZOLYLALKANE ANILIDES, METHOD FOR THEIR PREPARING AND USING AS ANTI-AGGREGATING AGENT | 2006 |
|
RU2322440C1 |
2-PIPERIDINO-5-(THIENYL-2)- AND 2-PIPERIDINO-5-(THIENYL-3)- 6H-1,3,4-THIADIAZINES HYDROBROMIDES POSSESSING ANTIAGGREGANT ACTION | 2010 |
|
RU2445310C2 |
ANTIAGGREGATING AGENTS | 1993 |
|
RU2088229C1 |
AGENT EXHIBITING ANTIAGGREGATORY ACTIVITY | 2019 |
|
RU2727508C1 |
2-CYCLOALKYLAMINO-5-THIENYL-1,3,4-THIADIAZINES, HYDROBROMIDES, WITH ANTIAGGREGANT ACTIVITY | 2008 |
|
RU2379306C1 |
METHOD OF PRODUCING DERIVATIVES OF ALPHA [2-OXO-2, 4, 5, 6,-7- HEXAHYDRO-5-THIENO (3, 2-C) PYRIDYL]-PHENYLACETIC ACID OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | 0 |
|
SU1389679A3 |
SUBSTITUTED O-[ω-(AZOL-1-YL)ALKYL]-N-PHENYLCARBAMATES AS AGENTS WITH ANTIAGGREGATORY ACTIVITY, METHOD FOR PRODUCTION THEREOF (VERSIONS) AND PHARMACEUTICAL COMPOSITION BASED THEREON | 2009 |
|
RU2488583C2 |
THROMBOCYTE AGGREGATION-INHIBITING N-CARB(GLUTAMINYL)OXYMETHYLIMIDAZO[4,5-E]BENZO[1,2-C;3,4-C']DIFUROXANE | 2012 |
|
RU2502739C9 |
Authors
Dates
2020-07-09—Published
2019-08-20—Filed